A detailed history of Berger Financial Group, Inc transactions in Amgen Inc stock. As of the latest transaction made, Berger Financial Group, Inc holds 4,516 shares of AMGN stock, worth $1.4 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
4,516
Previous 4,530 0.31%
Holding current value
$1.4 Million
Previous $1.3 Million 1.61%
% of portfolio
0.12%
Previous 0.14%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$268.87 - $324.56 $3,764 - $4,543
-14 Reduced 0.31%
4,516 $1.28 Million
Q4 2023

Feb 07, 2024

SELL
$255.7 - $288.46 $14,319 - $16,153
-56 Reduced 1.22%
4,530 $1.3 Million
Q3 2023

Nov 03, 2023

BUY
$218.65 - $271.46 $10,713 - $13,301
49 Added 1.08%
4,586 $1.23 Million
Q2 2023

Aug 10, 2023

SELL
$214.27 - $253.37 $6,428 - $7,601
-30 Reduced 0.66%
4,537 $1.01 Million
Q1 2023

Apr 24, 2023

BUY
$225.79 - $275.2 $225 - $275
1 Added 0.02%
4,567 $1.1 Million
Q4 2022

Jan 30, 2023

BUY
$229.03 - $291.01 $20,154 - $25,608
88 Added 1.97%
4,566 $1.2 Million
Q3 2022

Oct 27, 2022

BUY
$224.46 - $253.15 $64,195 - $72,400
286 Added 6.82%
4,478 $1.01 Million
Q2 2022

Aug 08, 2022

SELL
$230.71 - $256.74 $5,075 - $5,648
-22 Reduced 0.52%
4,192 $1.02 Million
Q1 2022

May 10, 2022

SELL
$219.27 - $242.57 $34,206 - $37,840
-156 Reduced 3.57%
4,214 $1.02 Million
Q4 2021

Jan 26, 2022

SELL
$198.88 - $227.6 $36,395 - $41,650
-183 Reduced 4.02%
4,370 $983,000
Q3 2021

Oct 28, 2021

BUY
$212.27 - $248.7 $10,188 - $11,937
48 Added 1.07%
4,553 $968,000
Q2 2021

Jul 29, 2021

BUY
$233.58 - $259.14 $32,701 - $36,279
140 Added 3.21%
4,505 $1.1 Million
Q1 2021

May 12, 2021

SELL
$221.91 - $258.6 $75,449 - $87,924
-340 Reduced 7.23%
4,365 $1.09 Million
Q4 2020

Feb 02, 2021

BUY
$216.38 - $257.67 $1.02 Million - $1.21 Million
4,705 New
4,705 $1.08 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Berger Financial Group, Inc Portfolio

Follow Berger Financial Group, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berger Financial Group, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Berger Financial Group, Inc with notifications on news.